EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause

Elisheva R Danan iD, Catherine Sowerby, Kristen E Ullman iD, Kristine Ensrud, Mary L Forte iD, Nicholas Zerzan, Maylen Anthony, Caleb Kalinowski, Hamdi I Abdi iD, Jessica K Friedman iD, Adrienne Landsteiner, Nancy Greer und 6 weitere

Annals of Internal Medicine · 2024-10 · 177 (10) · 1400-1414

DOI: 10.7326/annals-24-00610 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Internal Medicine, 2024-10. Verfasst von Elisheva R Danan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Care Delivery & Outcomes Research, VA Health Care System, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota (E.R…. Hauptthemen laut MEDLINE: Estrogens, Female Urogenital Diseases, Menopause. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Postmenopausal women commonly experience vulvovaginal, urinary, and sexual symptoms associated with genitourinary syndrome of menopause (GSM). PURPOSE: To evaluate effectiveness and harms of vaginal estrogen, nonestrogen hormone therapies, and vaginal moisturizers for treatment of GSM symptoms. DATA SOURCES: Medline, Embase, and CINAHL through 11 December 2023. STUDY SELECTION: Randomized controlled trials (RCTs) of at least 8 weeks' duration enrolling postmenopausal women with at least 1 GSM symptom and reporting effectiveness or harms of hormonal interventions or vaginal moisturizers. DATA EXTRACTION: Risk of bias and data extraction were performed by one reviewer and verified by a second reviewer. Certainty of evidence (COE) was assessed by one reviewer and verified by consensus. DATA SYNTHESIS: From 11 993 citations, 46 RCTs evaluating vaginal estrogen (k = 22), nonestrogen hormones (k = 16), vaginal moisturizers (k = 4), or multiple interventions (k = 4) were identified. Variation in populations, interventions, comparators, and outcomes precluded meta-analysis. Compared with placebo or no treatment, vaginal estrogen may improve vulvovaginal dryness, dyspareunia, most bothersome symptom, and treatment satisfaction. Compared with placebo, vaginal dehydroepiandrosterone (DHEA) may improve dryness, dyspareunia, and distress, bother, or interference from genitourinary symptoms; oral ospemifene may improve dryness, dyspareunia, and treatment satisfaction; and vaginal moisturizers may improve dryness (all low COE). Vaginal testosterone, systemic DHEA, vaginal oxytocin, and oral raloxifene or bazedoxifene may provide no benefit (low COE) or had uncertain effects (very low COE). Although studies did not report frequent serious harms, reporting was limited by short-duration studies that were insufficiently powered to evaluate infrequent serious harms. LIMITATIONS: Most studies were 12 weeks or less in duration and used heterogeneous GSM diagnostic criteria and outcome measures. Few studies enrolled women with a history of cancer. CONCLUSION: Vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may improve some GSM symptoms in the short term. Few long-term data exist on efficacy, comparative effectiveness, tolerability, and safety of GSM treatments. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality and Patient-Centered Outcomes Research Institute. (PROSPERO: CRD42023400684).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstrogensFemale Urogenital DiseasesMenopauseFemaleHumansAdministration, IntravaginalDehydroepiandrosteroneDyspareuniaEstrogen Replacement TherapyRandomized Controlled Trials as TopicSyndromeVaginal Creams, Foams, and JelliesTamoxifen

Substanzen

DehydroepiandrosteroneEstrogensVaginal Creams, Foams, and JelliesOspemifeneTamoxifen

Autor:innen und Institutionen

  • Center for Care Delivery & Outcomes Research, VA Health Care System, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota (E.R.D., S.D.).
  • Center for Care Delivery & Outcomes Research, VA Health Care System, Minneapolis, Minnesota (C.S., K.E.U., N.Z., M.A., C.K., A.L., N.G.).
  • Center for Care Delivery & Outcomes Research, VA Health Care System; Department of Medicine, University of Minnesota; and Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Mi…
  • Division of Health Policy & Management, School of Public Health, University of Minnesota, Minneapolis, Minnesota (M.L.F., H.I.A., M.B.).
  • VA Center for the Study of Healthcare Innovation, Implementation, and Policy, Los Angeles, California (J.K.F.).
  • Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota (R.N.).

ORCID-Profile: Elisheva R Danan, Kristen E Ullman, Mary L Forte, Hamdi I Abdi, Jessica K Friedman, Cynthia Fok

Zitieren

APA

Danan, E. R., Sowerby, C., Ullman, K. E., Ensrud, K., Forte, M. L., Zerzan, N., Anthony, M., Kalinowski, C., Abdi, H. I., Friedman, J. K., Landsteiner, A., Greer, N., Nardos, R., Fok, C., Dahm, P., Butler, M., Wilt, T. J., & Diem, S. (2024). Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause. Annals of Internal Medicine, 177(10), 1400-1414. https://doi.org/10.7326/annals-24-00610

Vancouver

Danan ER, Sowerby C, Ullman KE, Ensrud K, Forte ML, Zerzan N, et al. Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause. Annals of Internal Medicine. 2024;177(10):1400-1414. doi:10.7326/annals-24-00610

BibTeX
@article{Danan2024,
  author = {Danan, Elisheva R and Sowerby, Catherine and Ullman, Kristen E and Ensrud, Kristine and Forte, Mary L and Zerzan, Nicholas and Anthony, Maylen and Kalinowski, Caleb and Abdi, Hamdi I and Friedman, Jessica K and Landsteiner, Adrienne and Greer, Nancy and Nardos, Rahel and Fok, Cynthia and Dahm, Philipp and Butler, Mary and Wilt, Timothy J and Diem, Susan},
  title = {Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause},
  journal = {Annals of Internal Medicine},
  year = {2024},
  volume = {177},
  number = {10},
  pages = {1400--1414},
  doi = {10.7326/annals-24-00610}
}
Kostenlos starten →